annual total liabilities:
$111.33M+$25.03M(+29.00%)Summary
- As of today (June 2, 2025), LGND annual total liabilities is $111.33 million, with the most recent change of +$25.03 million (+29.00%) on December 31, 2024.
- During the last 3 years, LGND annual total liabilities has fallen by -$365.10 million (-76.63%).
- LGND annual total liabilities is now -84.70% below its all-time high of $727.68 million, reached on December 31, 2019.
Performance
LGND Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$109.90M-$1.43M(-1.29%)Summary
- As of today (June 2, 2025), LGND quarterly total liabilities is $109.90 million, with the most recent change of -$1.43 million (-1.29%) on March 31, 2025.
- Over the past year, LGND quarterly total liabilities has increased by +$2.55 million (+2.38%).
- LGND quarterly total liabilities is now -92.18% below its all-time high of $1.41 billion, reached on September 30, 2018.
Performance
LGND quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LGND Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +29.0% | +2.4% |
3 y3 years | -76.6% | -64.8% |
5 y5 years | -84.7% | -79.0% |
LGND Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -76.6% | +29.0% | -64.8% | +27.3% |
5 y | 5-year | -84.7% | +29.0% | -83.2% | +27.3% |
alltime | all time | -84.7% | +445.8% | -92.2% | +1405.5% |
LGND Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $109.90M(-1.3%) |
Dec 2024 | $111.33M(+29.0%) | $111.33M(-2.1%) |
Sep 2024 | - | $113.69M(+24.6%) |
Jun 2024 | - | $91.21M(-15.0%) |
Mar 2024 | - | $107.35M(+24.4%) |
Dec 2023 | $86.30M(-47.8%) | $86.30M(-14.8%) |
Sep 2023 | - | $101.33M(+8.7%) |
Jun 2023 | - | $93.21M(-43.4%) |
Mar 2023 | - | $164.76M(-0.3%) |
Dec 2022 | $165.18M(-65.3%) | $165.18M(-29.5%) |
Sep 2022 | - | $234.31M(-14.5%) |
Jun 2022 | - | $273.92M(-12.2%) |
Mar 2022 | - | $311.99M(-34.5%) |
Dec 2021 | $476.43M(-27.0%) | $476.43M(+3.2%) |
Sep 2021 | - | $461.59M(-1.7%) |
Jun 2021 | - | $469.77M(-14.5%) |
Mar 2021 | - | $549.28M(-15.9%) |
Dec 2020 | $652.76M(-10.3%) | $652.76M(+18.8%) |
Sep 2020 | - | $549.63M(+0.3%) |
Jun 2020 | - | $547.93M(+4.6%) |
Mar 2020 | - | $524.02M(-28.0%) |
Dec 2019 | $727.68M(+4.0%) | $727.68M(+4.4%) |
Sep 2019 | - | $696.89M(-8.3%) |
Jun 2019 | - | $760.38M(-8.8%) |
Mar 2019 | - | $834.01M(+19.2%) |
Dec 2018 | $699.89M(+177.3%) | $699.89M(-50.2%) |
Sep 2018 | - | $1.41B(+13.5%) |
Jun 2018 | - | $1.24B(+381.0%) |
Mar 2018 | - | $257.49M(+2.0%) |
Dec 2017 | $252.37M(+9.4%) | $252.37M(+6.2%) |
Sep 2017 | - | $237.57M(+3.0%) |
Jun 2017 | - | $230.62M(-0.1%) |
Mar 2017 | - | $230.94M(+0.1%) |
Dec 2016 | $230.73M(+2.0%) | $230.73M(+0.1%) |
Sep 2016 | - | $230.47M(+2.5%) |
Jun 2016 | - | $224.88M(+1.6%) |
Mar 2016 | - | $221.36M(-2.1%) |
Dec 2015 | $226.15M(-3.2%) | $226.15M(-1.5%) |
Sep 2015 | - | $229.52M(-2.6%) |
Jun 2015 | - | $235.71M(+2.1%) |
Mar 2015 | - | $230.83M(-1.2%) |
Dec 2014 | $233.62M(+324.0%) | $233.62M(+1.8%) |
Sep 2014 | - | $229.50M(+524.3%) |
Jun 2014 | - | $36.76M(-9.2%) |
Mar 2014 | - | $40.47M(-26.6%) |
Dec 2013 | $55.10M(-29.2%) | $55.10M(-3.1%) |
Sep 2013 | - | $56.86M(-5.7%) |
Jun 2013 | - | $60.30M(-11.0%) |
Mar 2013 | - | $67.77M(-12.9%) |
Dec 2012 | $77.78M(-30.8%) | $77.78M(+2.0%) |
Sep 2012 | - | $76.27M(-11.5%) |
Jun 2012 | - | $86.14M(-6.9%) |
Mar 2012 | - | $92.56M(-17.7%) |
Dec 2011 | $112.40M(+39.8%) | $112.40M(-6.4%) |
Sep 2011 | - | $120.10M(-1.6%) |
Jun 2011 | - | $122.11M(-5.4%) |
Mar 2011 | - | $129.14M(+60.6%) |
Dec 2010 | $80.41M(-41.8%) | $80.41M(-34.1%) |
Sep 2010 | - | $122.01M(-2.3%) |
Jun 2010 | - | $124.94M(-5.0%) |
Mar 2010 | - | $131.47M(-4.8%) |
Dec 2009 | $138.06M | $138.06M(+9.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2009 | - | $126.58M(-10.5%) |
Jun 2009 | - | $141.44M(-8.3%) |
Mar 2009 | - | $154.28M(-15.1%) |
Dec 2008 | $181.81M(+26.1%) | $181.81M(+25.2%) |
Sep 2008 | - | $145.24M(+3.0%) |
Jun 2008 | - | $141.00M(-0.5%) |
Mar 2008 | - | $141.73M(-1.7%) |
Dec 2007 | $144.16M(-51.7%) | $144.16M(-22.2%) |
Sep 2007 | - | $185.23M(-4.6%) |
Jun 2007 | - | $194.24M(-57.3%) |
Mar 2007 | - | $455.06M(+52.3%) |
Dec 2006 | $298.70M(-29.7%) | $298.70M(-38.2%) |
Sep 2006 | - | $483.06M(-7.9%) |
Jun 2006 | - | $524.43M(+2.2%) |
Mar 2006 | - | $513.05M(+20.7%) |
Dec 2005 | $425.04M(+4.2%) | $425.04M(+2.6%) |
Sep 2005 | - | $414.46M(+2.6%) |
Jun 2005 | - | $404.11M(-0.8%) |
Mar 2005 | - | $407.21M(-0.1%) |
Dec 2004 | $407.78M(+16.0%) | $407.78M(+64.6%) |
Sep 2004 | - | $247.70M(+4.4%) |
Jun 2004 | - | $237.32M(+1.5%) |
Mar 2004 | - | $233.82M(-33.5%) |
Dec 2003 | $351.60M(+74.6%) | $351.60M(+67.3%) |
Sep 2003 | - | $210.20M(+5.2%) |
Jun 2003 | - | $199.88M(-1.6%) |
Mar 2003 | - | $203.15M(+0.9%) |
Dec 2002 | $201.41M(+14.9%) | $201.41M(+439.1%) |
Sep 2002 | - | $37.36M(-8.1%) |
Jun 2002 | - | $40.65M(-53.8%) |
Mar 2002 | - | $87.88M(-49.9%) |
Dec 2001 | $175.35M(+4.0%) | $175.35M(+3.7%) |
Sep 2001 | - | $169.14M(-0.7%) |
Jun 2001 | - | $170.33M(+3.6%) |
Mar 2001 | - | $164.45M(-2.4%) |
Dec 2000 | $168.55M(+5.2%) | $168.55M(+16.0%) |
Sep 2000 | - | $145.35M(-0.3%) |
Jun 2000 | - | $145.80M(+2.5%) |
Mar 2000 | - | $142.20M(-11.2%) |
Dec 1999 | $160.20M(-4.3%) | $160.20M(-9.3%) |
Sep 1999 | - | $176.70M(+15.0%) |
Jun 1999 | - | $153.60M(+1.7%) |
Mar 1999 | - | $151.10M(-9.7%) |
Dec 1998 | $167.40M(+129.0%) | $167.40M(+41.4%) |
Sep 1998 | - | $118.40M(+72.6%) |
Jun 1998 | - | $68.60M(+2.8%) |
Mar 1998 | - | $66.70M(-8.8%) |
Dec 1997 | $73.10M(+8.1%) | $73.10M(+18.3%) |
Sep 1997 | - | $61.80M(-4.5%) |
Jun 1997 | - | $64.70M(+1.4%) |
Mar 1997 | - | $63.80M(-5.6%) |
Dec 1996 | $67.60M(+3.2%) | $67.60M(+14.4%) |
Sep 1996 | - | $59.10M(-7.7%) |
Jun 1996 | - | $64.00M(+0.9%) |
Mar 1996 | - | $63.40M(-3.2%) |
Dec 1995 | $65.50M(+221.1%) | $65.50M(+8.3%) |
Sep 1995 | - | $60.50M(+216.8%) |
Mar 1995 | - | $19.10M(-6.4%) |
Dec 1994 | $20.40M | $20.40M(+5.2%) |
Sep 1994 | - | $19.40M(+158.7%) |
Jun 1994 | - | $7.50M(+2.7%) |
Mar 1994 | - | $7.30M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total liabilities?
- What is the all time high annual total liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual total liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly total liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total liabilities?
The current annual total liabilities of LGND is $111.33M
What is the all time high annual total liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total liabilities is $727.68M
What is Ligand Pharmaceuticals Incorporated annual total liabilities year-on-year change?
Over the past year, LGND annual total liabilities has changed by +$25.03M (+29.00%)
What is Ligand Pharmaceuticals Incorporated quarterly total liabilities?
The current quarterly total liabilities of LGND is $109.90M
What is the all time high quarterly total liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total liabilities is $1.41B
What is Ligand Pharmaceuticals Incorporated quarterly total liabilities year-on-year change?
Over the past year, LGND quarterly total liabilities has changed by +$2.55M (+2.38%)